Pharmacy Benefit Manager Transparency Act of 2005
Latest action · May 13, 2005 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 14, 2005
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmacy Benefit Manager Transparency Act of 2005 - Prohibits any pharmaceutical drug manufacturer from having a controlling interest in an entity that is a pharmacy benefit manager. Allows the Secretary of Health and Human Services to issue civil penalties for violations as necessary.
Prohibits pharmacy benefit managers from making drug interchanges: (1) to a drug with a greater cost; (2) without disclosure to the individual of the savings associated with the interchange; or (3) from a drug with generic equivalents to a drug without generic equivalents, unless the latter is lower in cost than each of the generic equivalents of the drug from which the prescription would be changed.
Requires pharmacy benefit managers to annually disclose all compensation received from drug manufacturers to the Antitrust Division of the Department of Justice (DOJ) and to the client plans of such manager.
Cosponsors 2
Members who signed on, in the order they did. Signatures ran from Apr 14, 2005 to Dec 8, 2005; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-KS | Jerry Moran | Original | Apr 14, 2005 |
| R-AR | John Boozman | Dec 8, 2005 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 14, 2005 |
| Health Subcommittee | Referred May 13, 2005 |
Actions 3
Everything that happened, newest first.
- May 13, 2005Referred to the Subcommittee on Health.
- Apr 14, 2005Introduced in House
- Apr 14, 2005Referred to the House Committee on Energy and Commerce.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To ensure integrity in the operation of pharmacy benefit managers.
- Short Titles as Introduced
- Pharmacy Benefit Manager Transparency Act of 2005
Subjects
Assigned by the Library of Congress. Policy area: Law.
- Business records
- Commerce
- Consumer discounts
- Consumer education
- Consumer protection
- Contracts
- Drug industry
- Drug utilization
- Drugs
- Fees
- Finance and Financial Sector
- Financial statements
- Fines (Penalties)
- Generic drugs
- Government Operations and Politics
- Government paperwork
- Health
- Health care fraud
- Health insurance
- Insurance companies
- Law
- Medical statistics
- Patients' rights
- Pharmacies
- Prescription pricing
- Restrictive trade practices
Text 1
Each version as it was printed, newest first.
- Apr 14, 2005Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.